Jan. 5 at 6:05 PM
$VTVT TD Cowen Initiates Coverage with a Buy Rating and
$67 Price Target | VTVT Stock
On January 5, 2026, TD Cowen initiated coverage on vTv Therapeutics (VTVT) with a "Buy" rating, setting a price target of
$67.00. This indicates a strong potential upside for investors considering the current valuation of
$VTVT.
